Overview

Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes

Status:
Completed
Trial end date:
2018-07-31
Target enrollment:
Participant gender:
Summary
To describe the rate of post-collection TU to testosterone conversion, as manifested by increases in testosterone concentration, in Plain tubes held at room temperature and sodium fluoride (NaF)-ethylenediaminetetraacetic acid (EDTA) tubes held at room temperature or on ice prior to centrifugation
Phase:
Phase 1
Details
Lead Sponsor:
Clarus Therapeutics, Inc.
Collaborator:
Celerion; Syneos Health; ARUP Laboratories
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate